Search Results 761-770 of 17663 for protein intake optimization

  1. Clinical trials - Oncology (Medical)

    Cohort 1 includes blood collections for in vitro studies which are a component of NIH-funded Project 3 within the Mayo Clinic Pancreatic SPORE, “Optimal ...

  2. Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later ... generation sequencing or absence of MTAP protein in a tumor detected by IHC. ... requirements 3 ...

  3. What is peripheral artery disease? - Mayo Clinic

    ... optimizing medical care and other treatment modalities. ... Admissions Requirements · Degree Programs · Student ... Admissions Requirements · Student & Faculty ...

  4. Pharmacogenomics and Post-Operative Nausea and Vomiting - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy ...

  5. Diet in Altering Disease Progression in Patients with Prostate Cancer on Active Surveillance - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy ...

  6. A Study of JNJ-68284528, a Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later ... Measurable disease at Screening as defined by any of the following: Serum monoclonal paraprotein (M-protein) ...

  7. WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later ... requirements; Willing to return to ... AZD1775 is an inhibitor of breast cancer resistance protein.

  8. A Study to Compare Cabozantinib versus Sunitinib to Treat Metastatic Variant Histology Renal Cell Carcinoma Patients - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later ... Urine protein/creatinine ratio (UPCR) ≤ 1 mg/mg ... The subject is capable of understanding and complying with ...

  9. Individualized Medicine - 2026 Archives - Mayo Clinic News Network

    Mayo Clinic researchers link Parkinson's-related protein to faster Alzheimer's progression in women featured image. Mayo Clinic researchers link Parkinson's ...

  10. Analysis of Tumor and Immune Cells Isolated from Tissue and Urine of Bladder Cancer Patients - Mayo Clinic

    The purpose of this study is to optimize methods in order to analyze immune cell profile in tissue and urine of bladder cancer patients. Participation ...